<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6103530 - Medium for proliferating central nervous system stem cells includes standard ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor"><meta name="DC.contributor" content="Melissa Carpenter" scheme="inventor"><meta name="DC.contributor" content="Cytotherapeutics, Inc." scheme="assignee"><meta name="DC.date" content="1998-10-23" scheme="dateSubmitted"><meta name="DC.description" content="Isolation, characterization, proliferation, differentiation and transplantation of mammalian neural stem cells is disclosed."><meta name="DC.date" content="2000-8-15" scheme="issued"><meta name="DC.relation" content="US:4753635" scheme="references"><meta name="DC.relation" content="US:4980174" scheme="references"><meta name="DC.relation" content="US:5082670" scheme="references"><meta name="DC.relation" content="US:5175103" scheme="references"><meta name="DC.relation" content="US:5411883" scheme="references"><meta name="DC.relation" content="US:5580777" scheme="references"><meta name="DC.relation" content="US:5612211" scheme="references"><meta name="DC.relation" content="US:5639618" scheme="references"><meta name="DC.relation" content="US:5672499" scheme="references"><meta name="DC.relation" content="US:5688692" scheme="references"><meta name="DC.relation" content="US:5750376" scheme="references"><meta name="DC.relation" content="US:5753506" scheme="references"><meta name="DC.relation" content="WO:1989003872:A1" scheme="references"><meta name="DC.relation" content="WO:1990006757:A1" scheme="references"><meta name="DC.relation" content="WO:1991002003:A1" scheme="references"><meta name="DC.relation" content="WO:1991009936:A1" scheme="references"><meta name="DC.relation" content="WO:1991017141:A2" scheme="references"><meta name="DC.relation" content="WO:1993001275:A1" scheme="references"><meta name="DC.relation" content="WO:1993009802:A2" scheme="references"><meta name="DC.relation" content="WO:1994009119:A1" scheme="references"><meta name="DC.relation" content="WO:1994010292:A1" scheme="references"><meta name="DC.relation" content="WO:1994016718:A1" scheme="references"><meta name="DC.relation" content="WO:1995000632:A1" scheme="references"><meta name="DC.relation" content="WO:1996015226:A1" scheme="references"><meta name="citation_reference" content="Anchan et al., &quot;EGF and TGF-.∝. Stimulate Retinal Neuroepithelial Cell Proliferation in Vitro,&quot; Neuron, 6(6):923-936 (1991)."><meta name="citation_reference" content="Anchan et al., EGF and TGF . . Stimulate Retinal Neuroepithelial Cell Proliferation in Vitro, Neuron, 6(6):923 936 (1991)."><meta name="citation_reference" content="Andres &quot;Removal and reimplantation of the parietal cortex of mice during the first nine days of life: consequences for the barrelfield&quot; Journal of Neural Transplantation 1(1):11-12 (1989) (abstract)."><meta name="citation_reference" content="Andres Removal and reimplantation of the parietal cortex of mice during the first nine days of life: consequences for the barrelfield Journal of Neural Transplantation 1(1):11 12 (1989) (abstract)."><meta name="citation_reference" content="Blakemore &amp; Crang., &quot;Extensive Oligodendrocyte Remyelination Following Injection of Cultured Central Nervous System,&quot; Developmental Neuroscience, 10:1-11 (1988)."><meta name="citation_reference" content="Blakemore &amp; Crang., Extensive Oligodendrocyte Remyelination Following Injection of Cultured Central Nervous System, Developmental Neuroscience, 10:1 11 (1988)."><meta name="citation_reference" content="Bossart et al., &quot;Epidermal growth factor stimulates colony formation and non-neuronal marker protein expression by human neuroblastoma in methylcellulose culture&quot;, Anticancer Res. 9: 1496-1504, (1989)."><meta name="citation_reference" content="Bossart et al., Epidermal growth factor stimulates colony formation and non neuronal marker protein expression by human neuroblastoma in methylcellulose culture , Anticancer Res. 9: 1496 1504, (1989)."><meta name="citation_reference" content="Calof et al., &quot;Analysis of Neurogenesis in a Mammalian Neuroepithelium: Proliferation and Differentiation of an Olfactory Neuron Precursor in Vitro,&quot; Neuron, 3:115-127 (1989)."><meta name="citation_reference" content="Calof et al., &quot;Regulation of Neurogenesis and neuronal differentiation in primary and immortalized cells from Mouse olfactory epithellum&quot;, J. Cell Biol. 109(4 part 2): 57A, (1989)."><meta name="citation_reference" content="Calof et al., Analysis of Neurogenesis in a Mammalian Neuroepithelium: Proliferation and Differentiation of an Olfactory Neuron Precursor in Vitro, Neuron, 3:115 127 (1989)."><meta name="citation_reference" content="Calof et al., Regulation of Neurogenesis and neuronal differentiation in primary and immortalized cells from Mouse olfactory epithellum , J. Cell Biol. 109(4 part 2): 57A, (1989)."><meta name="citation_reference" content="Cattaneo and McKay., &quot;Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor,&quot; Nature, 347:762-765 (1990)."><meta name="citation_reference" content="Cattaneo and McKay., Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor, Nature, 347:762 765 (1990)."><meta name="citation_reference" content="Cattaneo et al., &quot;Non-virally mediated gene transfer into human central nervous system precursor cells&quot;, Mol. Brain Res., 42: 161-66, (1996)."><meta name="citation_reference" content="Cattaneo et al., Non virally mediated gene transfer into human central nervous system precursor cells , Mol. Brain Res., 42: 161 66, (1996)."><meta name="citation_reference" content="Cepko et al., &quot;Immortalization of neural cells via retrovirus-mediated oncogene transduction,&quot; Ann. Rev. Neurosci., 12:47-65 (1989)."><meta name="citation_reference" content="Cepko et al., Immortalization of neural cells via retrovirus mediated oncogene transduction, Ann. Rev. Neurosci., 12:47 65 (1989)."><meta name="citation_reference" content="Drago et al., &quot;Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I&quot;, Proc. Natl. Acad. Sci. USA 88(6): 2199-21203, (1991)."><meta name="citation_reference" content="Drago et al., Fibroblast growth factor mediated proliferation of central nervous system precursors depends on endogenous production of insulin like growth factor I , Proc. Natl. Acad. Sci. USA 88(6): 2199 21203, (1991)."><meta name="citation_reference" content="Federoff et al. &quot;Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia&quot; (Proc. Natl. Acad. Sci. USA 89(5): 1636-1640, 1992)."><meta name="citation_reference" content="Federoff et al. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia ( Proc. Natl. Acad. Sci. USA 89(5): 1636 1640, 1992)."><meta name="citation_reference" content="Franklin et al., &quot;Transplanted type-1 astrocyystes facilities repair of demyelinating lesions by host oligodendrycytes in adult rat spinal cord&quot;, Neuropathol Appl Neurobiol 17(3), 244, (1991)."><meta name="citation_reference" content="Franklin et al., Transplanted type 1 astrocyystes facilities repair of demyelinating lesions by host oligodendrycytes in adult rat spinal cord , Neuropathol Appl Neurobiol 17(3), 244, (1991)."><meta name="citation_reference" content="Frederiksen et al., &quot;Immortalization of precursor cells from the mammalian CNS,&quot; Neuron, 1:439-448 (1988)."><meta name="citation_reference" content="Frederiksen et al., &quot;Proliferation and differentiation of rat neuroepithelial precursor cells in vivo,&quot; The Journal of Neuroscience 8(4): 1144-1151 (1988)."><meta name="citation_reference" content="Frederiksen et al., Immortalization of precursor cells from the mammalian CNS, Neuron, 1:439 448 (1988)."><meta name="citation_reference" content="Frederiksen et al., Proliferation and differentiation of rat neuroepithelial precursor cells in vivo, The Journal of Neuroscience 8(4): 1144 1151 (1988)."><meta name="citation_reference" content="Geller et al., &quot;A Defective HSV-1 vector expresses Escherichia coli .β.-galactosidase in cultured peripheral neurons,&quot; Science, 241:1667-1669 (1988)."><meta name="citation_reference" content="Geller et al., A Defective HSV 1 vector expresses Escherichia coli . . galactosidase in cultured peripheral neurons, Science, 241:1667 1669 (1988)."><meta name="citation_reference" content="Gensburger et al., &quot;Brain basic fibroblast growth factor stimulates the proliferation of rat neuronal precursor cells in vivo,&quot; FEBS Letts, 217(1):1-5 (1987)."><meta name="citation_reference" content="Gensburger et al., Brain basic fibroblast growth factor stimulates the proliferation of rat neuronal precursor cells in vivo, FEBS Letts, 217(1):1 5 (1987)."><meta name="citation_reference" content="Hall &amp; Watt, &quot;Stem cells: the generation and maintenance of cellular diversity,&quot; Development, 106:619-633 (1989)."><meta name="citation_reference" content="Hall &amp; Watt, Stem cells: the generation and maintenance of cellular diversity, Development, 106:619 633 (1989)."><meta name="citation_reference" content="Hammang et al., &quot;Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment&quot;, Experimental Neurology 147:84-95 (1997)."><meta name="citation_reference" content="Hammang et al., Myelination following transplantation of EGF responsive neural stem cells into a myelin deficient environment , Experimental Neurology 147:84 95 (1997)."><meta name="citation_reference" content="Hoffman et al., &quot;Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF,&quot; Exp. Neurol. 122:100-106 (1993)."><meta name="citation_reference" content="Hoffman et al., Transplantation of a polymer encapsulated cell line genetically engineered to release NGF, Exp. Neurol. 122:100 106 (1993)."><meta name="citation_reference" content="Hunter et al., &quot;Growth factor responses of enriched bipotential glial progenitors,&quot; Developmental Brain Research, 54(2):235-248 (1990)."><meta name="citation_reference" content="Hunter et al., Growth factor responses of enriched bipotential glial progenitors, Developmental Brain Research, 54(2):235 248 (1990)."><meta name="citation_reference" content="Isacson et al., &quot;A primate model of Huntingdon&#39;s disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen&quot;, Exp. Brain, Res. 75(1): 213-220, (1989)."><meta name="citation_reference" content="Isacson et al., A primate model of Huntingdon s disease: cross species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate putamen , Exp. Brain, Res. 75(1): 213 220, (1989)."><meta name="citation_reference" content="Jaenisch et al., &quot;The cells of primitive neuroectodermal tumours may undergo differentiation and, eventually, may be transformed to neurons, glial cells, and ependymal cells&quot;, Acta Histochemica Supplementband 42: 139-147, (1992)."><meta name="citation_reference" content="Jaenisch et al., The cells of primitive neuroectodermal tumours may undergo differentiation and, eventually, may be transformed to neurons, glial cells, and ependymal cells , Acta Histochemica Supplementband 42: 139 147, (1992)."><meta name="citation_reference" content="Kaplan et al., &quot;Neurogenesis in the 3-month-old rat visual cortex,&quot; J. Comp. Neurol., 195:323 (1981)."><meta name="citation_reference" content="Kaplan et al., Neurogenesis in the 3 month old rat visual cortex, J. Comp. Neurol., 195:323 (1981)."><meta name="citation_reference" content="Kesslak et al. ( Exp Neurology 94(3): 615 626, 1989)."><meta name="citation_reference" content="Kesslak et al. (Exp Neurology 94(3): 615-626, 1989)."><meta name="citation_reference" content="Kumar et al. &quot;Identification of a Set of Genes with Developmental Down-Regulated Expression in the Mouse Brain,&quot; Biochemical and Biophysical Research Comm., 185(3):1155-1161 (1992)."><meta name="citation_reference" content="Kumar et al. Identification of a Set of Genes with Developmental Down Regulated Expression in the Mouse Brain, Biochemical and Biophysical Research Comm., 185(3):1155 1161 (1992)."><meta name="citation_reference" content="Lendahl et al., &quot;CNS stem cells express a new class of intermediate filament protein,&quot; Cell, 60 585-595 (1990)."><meta name="citation_reference" content="Lendahl et al., CNS stem cells express a new class of intermediate filament protein, Cell, 60 585 595 (1990)."><meta name="citation_reference" content="Lin et al., &quot;GDNF: A Glial Cell Line-Derived Neurotrophic Factor Midbrain Dopaminergic Neuron,&quot; Science, 260:1130 (1993)."><meta name="citation_reference" content="Lin et al., GDNF: A Glial Cell Line Derived Neurotrophic Factor Midbrain Dopaminergic Neuron, Science, 260:1130 (1993)."><meta name="citation_reference" content="Lindvall et al. &quot;Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson&#39;s disease&quot;, (Archives of Neurology 46(6): 615-631, 1989)."><meta name="citation_reference" content="Lindvall et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson s disease , ( Archives of Neurology 46(6): 615 631, 1989)."><meta name="citation_reference" content="Lo et al., &quot;V-myc Immortalizationof Early Rat Neural Crest Cells Yields a Clonal Cell Line Which Generates Both Glial and Adrenergic Progenitor Cells,&quot; Developmental Biology, 145:139-153 (1991)."><meta name="citation_reference" content="Lo et al., V myc Immortalizationof Early Rat Neural Crest Cells Yields a Clonal Cell Line Which Generates Both Glial and Adrenergic Progenitor Cells, Developmental Biology, 145:139 153 (1991)."><meta name="citation_reference" content="Morrison et al., &quot;Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor,&quot; Science, 238:72-75 (1987)."><meta name="citation_reference" content="Morrison et al., Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor, Science, 238:72 75 (1987)."><meta name="citation_reference" content="Potten &amp; Loeffler, &quot;Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the Crypt,&quot; Development, 110:1001-1020 (1990)."><meta name="citation_reference" content="Potten &amp; Loeffler, Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the Crypt, Development, 110:1001 1020 (1990)."><meta name="citation_reference" content="Price et al., &quot;Cell lineage in the rat cerebral cortex: a study using retroviral-mediated gene transfer&quot;, Development 104(3): 473-482, (1988)."><meta name="citation_reference" content="Price et al., Cell lineage in the rat cerebral cortex: a study using retroviral mediated gene transfer , Development 104(3): 473 482, (1988)."><meta name="citation_reference" content="Raff et al., &quot;A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium,&quot; Nature 303:390-396 (1983)."><meta name="citation_reference" content="Raff et al., A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium, Nature 303:390 396 (1983)."><meta name="citation_reference" content="Rakic, &quot;Limits of neurogenesis in primates,&quot; Science 227:1054 (1985)."><meta name="citation_reference" content="Rakic, Limits of neurogenesis in primates, Science 227:1054 (1985)."><meta name="citation_reference" content="Reh et al., &quot;Age of differentiation determines rat retinal germinal cell phenotype: Induction of differentiation by dissociation,&quot; The Journal of Neuroscience, 9(12):4179-4189 (1989)."><meta name="citation_reference" content="Reh et al., Age of differentiation determines rat retinal germinal cell phenotype: Induction of differentiation by dissociation, The Journal of Neuroscience, 9(12):4179 4189 (1989)."><meta name="citation_reference" content="Renfranz et al., &quot;Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain&quot; Cell 66:713-729 (1991)."><meta name="citation_reference" content="Renfranz et al., Region specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain Cell 66:713 729 (1991)."><meta name="citation_reference" content="Reynolds &amp; Weiss., &quot;Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system,&quot; Science, 255:1707-1710 (1992)."><meta name="citation_reference" content="Reynolds &amp; Weiss., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, 255:1707 1710 (1992)."><meta name="citation_reference" content="Reynolds et al., &quot;A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes,&quot; J. Neurosci. 12(11):4565-4574 (1992)."><meta name="citation_reference" content="Reynolds et al., A multipotent EGF responsive striatal embryonic progenitor cell produces neurons and astrocytes, J. Neurosci. 12(11):4565 4574 (1992)."><meta name="citation_reference" content="Richardson et al., &quot;A role for platelet-derived growth factor in normal gliogenesis in the central nervous system&quot;, Cell, 53: 309-319, 1988)."><meta name="citation_reference" content="Richardson et al., A role for platelet derived growth factor in normal gliogenesis in the central nervous system , Cell, 53: 309 319, 1988)."><meta name="citation_reference" content="Snyder et al., &quot;Multipotent neural cell lines can engraft and participate in development of mouse cerebellum&quot;, Cell 68:33-51 (1992)."><meta name="citation_reference" content="Snyder et al., Multipotent neural cell lines can engraft and participate in development of mouse cerebellum , Cell 68:33 51 (1992)."><meta name="citation_reference" content="Stemple &amp; Anderson, &quot;Isolation of a stem cell for neurons and glia from the mammalian neural crest&quot;, Cell 71:1-20, (1992)."><meta name="citation_reference" content="Stemple &amp; Anderson, Isolation of a stem cell for neurons and glia from the mammalian neural crest , Cell 71:1 20, (1992)."><meta name="citation_reference" content="Temple et al., &quot;Divison and differentiation of isolated CNS blast cells in microculture,&quot; Nature, 340:471-473 (1989)."><meta name="citation_reference" content="Temple et al., Divison and differentiation of isolated CNS blast cells in microculture, Nature, 340:471 473 (1989)."><meta name="citation_reference" content="Tohyama et al., &quot;Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells&quot;, Lab. Invest., 66: 303-313, (1992)."><meta name="citation_reference" content="Tohyama et al., Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells , Lab. Invest., 66: 303 313, (1992)."><meta name="citation_reference" content="Vescovi et al., &quot;Continual proliferation of EGF-dependent progenitor cells of the embryonic human CNS in vitro&quot;Society for Neuroscience Abstracts, vol. 19, Abstract #360.12 (1993)."><meta name="citation_reference" content="Vescovi et al., Continual proliferation of EGF dependent progenitor cells of the embryonic human CNS in vitro Society for Neuroscience Abstracts , vol. 19, Abstract 360.12 (1993)."><meta name="citation_reference" content="Wendt et al. &quot;Regeneration of rat hippocampal fimbria fibers after fimbria transection and peripheral nerve or fetal hippocampal implantation.&quot;, (Exp. Neurology 79(2): 452-461, 1983)."><meta name="citation_reference" content="Wendt et al. Regeneration of rat hippocampal fimbria fibers after fimbria transection and peripheral nerve or fetal hippocampal implantation. , ( Exp. Neurology 79(2): 452 461, 1983)."><meta name="citation_reference" content="Yamada et al., Growth of cells in hormonally defined media Book A Cold Spring Harbor Laboratory, 1982 Cold Spring Harbor conferences on cell proliferation, vol. 9, 131 143."><meta name="citation_reference" content="Yamada et al., Growth of cells in hormonally defined media--Book A Cold Spring Harbor Laboratory, 1982--Cold Spring Harbor conferences on cell proliferation, vol. 9, 131-143."><meta name="citation_patent_number" content="US:6103530"><meta name="citation_patent_application_number" content="US:09/178,035"><link rel="canonical" href="http://www.google.com/patents/US6103530"/><meta property="og:url" content="http://www.google.com/patents/US6103530"/><meta name="title" content="Patent US6103530 - Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor"/><meta name="description" content="Isolation, characterization, proliferation, differentiation and transplantation of mammalian neural stem cells is disclosed."/><meta property="og:title" content="Patent US6103530 - Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("H6ntU_bRDejgsATT64HoDg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("NOR"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("H6ntU_bRDejgsATT64HoDg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("NOR"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6103530?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6103530"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=_8pQBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6103530&amp;usg=AFQjCNEkS6d4HN-OXbOop5cRc6KiXP96ZQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6103530.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6103530.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6103530" style="display:none"><span itemprop="description">Isolation, characterization, proliferation, differentiation and transplantation of mammalian neural stem cells is disclosed....</span><span itemprop="url">http://www.google.com/patents/US6103530?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6103530 - Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6103530 - Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor" title="Patent US6103530 - Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6103530 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 09/178,035</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Aug 15, 2000</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Oct 23, 1998</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Sep 5, 1997</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2302484A1">CA2302484A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2302484C">CA2302484C</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1007636A2">EP1007636A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1007636B1">EP1007636B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5968829">US5968829</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6498018">US6498018</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6777233">US6777233</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20020164309">US20020164309</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060240553">US20060240553</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20080107633">US20080107633</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1999011758A2">WO1999011758A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1999011758A3">WO1999011758A3</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">09178035, </span><span class="patent-bibdata-value">178035, </span><span class="patent-bibdata-value">US 6103530 A, </span><span class="patent-bibdata-value">US 6103530A, </span><span class="patent-bibdata-value">US-A-6103530, </span><span class="patent-bibdata-value">US6103530 A, </span><span class="patent-bibdata-value">US6103530A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Melissa+Carpenter%22">Melissa Carpenter</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Cytotherapeutics,+Inc.%22">Cytotherapeutics, Inc.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6103530.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6103530.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6103530.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (24),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (92),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (17),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (33),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (12)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6103530&usg=AFQjCNHTw4ZI7OPxGclgDN_Uj0uLiImLng">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6103530&usg=AFQjCNFyc0m2-vKPIQvU96YWiR8hFh4U0w">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6103530A%26KC%3DA%26FT%3DD&usg=AFQjCNGUItFgP9Fw-2gN2S1ev15exiNBpQ">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129055060" lang="EN" load-source="ifi">Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor</invention-title></span><br><span class="patent-number">US 6103530 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA38111189" lang="EN" load-source="patent-office"> <div class="abstract">Isolation, characterization, proliferation, differentiation and transplantation of mammalian neural stem cells is disclosed.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(4)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6103530-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6103530-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6103530-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6103530-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6103530-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6103530-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6103530-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6103530-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(2)</span></span></div><div class="patent-text"><div mxw-id="PCLM5610491" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>I claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A culture medium for proliferating mammalian neural stem cells, the media comprising cell viability and cell proliferation effective amounts of the following components:<div class="claim-text">(a) a standard defined basal medium;</div> <div class="claim-text">(b) a supplemental carbohydrate, wherein the carbohydrate is present at a concentration between 0.2% and 1.0% weight/volume (w/v);</div> <div class="claim-text">(c) a supplemental buffer, such that the pH of the culture medium is between pH 6 and pH 8;</div> <div class="claim-text">(d) supplemental agents, wherein the agents are selected from the group consisting of insulin, transferrin, progesterone, selenium, putrescine, and combinations thereof;</div> <div class="claim-text">(e) one or more growth factors that stimulate proliferation of neural stem cells, wherein the growth factors are present at a concentration of between 0.2 ng/ml and 200 ng/ml, and;</div> <div class="claim-text">(f) leukocyte inhibitory factor (LIF), wherein the LIF is present at a concentration of between 0.1 ng/ml and 500 ng/ml.</div> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The medium of claim 1 further comprising heparin.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67517476" lang="EN" load-source="patent-office" class="description">
    <heading>RELATED APPLICATIONS</heading> <p>This is a divisional application of U.S. patent application Ser. No. 08/926,313, filed Sep. 5, 1997.</p>
    <heading>TECHNICAL FIELD OF THE INVENTION</heading> <p>This invention relates to isolation of human central nervous system stem cells, and methods and media for proliferating, differentiating and transplanting them.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>During development of the central nervous system ("CNS"), multipotent precursor cells, also known as neural stem cells, proliferate, giving rise to transiently dividing progenitor cells that eventually differentiate into the cell types that compose the adult brain. Neural stem cells are classically defined as having the ability to self-renew (i.e., form more stem cells), to proliferate, and to differentiate into multiple different phenotypic lineages, including neurons, astrocytes and oligodendrocytes.</p>
    <p>These neural stem cells have been isolated from several mammalian species, including mice, rats, pigs and humans. See, e.g., WO 93/01275, WO 94/09119, WO 94/10292, WO 94/16718 and Cattaneo et al., Mol. Brain Res., 42, pp. 161-66 (1996), all herein incorporated by reference.</p>
    <p>Human CNS neural stem cells, like their rodent homologues, when maintained in a mitogen-containing (typically epidermal growth factor or epidermal growth factor plus basic fibroblast growth factor), serum-free culture medium, grow in suspension culture to form aggregates of cells known as "neurospheres". In the prior art, human neural stem cells have doubling rates of about 30 days. See, e.g., Cattaneo et al., Mol. Brain Res., 42, pp. 161-66 (1996). Upon removal of the mitogen(s) and provision of a substrate, the stem cells differentiate into neurons, astrocytes and oligodendrocytes. In the prior art, the majority of cells in the differentiated cell population have been identified as astrocytes, with very few neurons (&lt;10%) being observed.</p>
    <p>There remains a need to increase the rate of proliferation of neural stem cell cultures. There also remains a need to increase the number of neurons in the differentiated cell population. There further remains a need to improve the viability of neural stem cell grafts upon implantation into a host.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>This invention provides novel human central nervous system stem cells, and methods and media for proliferating, differentiating and transplanting them. In one embodiment, this invention provides novel human stem cells with a doubling rate of between 5-10 days, as well as defined growth media for prolonged proliferation of human neural stem cells. The invention also provides differentiated cell populations of human neural stem cells that provide previously unobtainable large numbers of neurons, as well as astrocytes and oligodendrocytes. This invention also provides novel methods for transplanting neural stem cells that improve the viability of the graft upon implantation in a host.</p>
    <heading>BRIEF DESCRIPTION OF THE DRAWINGS</heading> <p>FIG. 1 shows a representation of spheres of proliferating 9 FBr human neural stem cells (passage 6) derived from human forebrain tissue.</p>
    <p>FIG. 2, Panel A, shows a growth curve for a human neural stem cell line designated 6.5 Fbr cultured in (a) defined media containing EGF, FGF and leukemia inhibitory factor ("LIF") (shown as closed diamonds), and (b) the same media but without LIF (shown as open diamonds); Panel B shows a growth curve for a human neural stem cell line designated 9 Fbr cultured in (a) defined media containing EGF, FGF and LIF (shown as closed diamonds), and (b) the same media but without LIF (shown as open diamonds); Panel C shows a growth curve for a human neural stem cell line designated 9.5 Fbr cultured in (a) defined media containing EGF, FGF and LIF (shown as closed diamonds), and (b) the same media but without LIF (shown as open diamonds); Panel D shows a growth curve for a human neural stem cell line designated 10.5 Fbr cultured in (a) defined media containing EGF, FGF and leukemia inhibitory factor ("LIF") (shown as closed diamonds), and (b) the same media but without LIF (shown as open diamonds).</p>
    <p>FIG. 3 shows a growth curve for a human neural stem cell line designated 9 Fbr cultured in (a) defined media containing EGF and basic fibroblast growth factor ("bFGF") (shown as open diamonds), and (b) defined media with EGF but without bFGF (shown as closed diamonds).</p>
    <p>FIG. 4 shows a graph of cell number versus days in culture for an Mx-1 conditionally immortalized human glioblast line derived from a human neural stem cell line. The open squares denote growth in the presence of interferon, the closed diamonds denote growth in the absence of interferon.</p>
    <heading>DETAILED DESCRIPTION OF THE INVENTION</heading> <p>This invention relates to isolation, characterization, proliferation, differentiation and transplantation of CNS neural stem cells.</p>
    <p>In one embodiment the invention provides novel human CNS stem cells isolated from the forebrain. We have isolated 4 neural stem cell lines from human forebrain, all of which exhibit neural stem cell properties; namely, the cells are self renewing, the cells proliferate for long periods in mitogen containing serum free medium, and the cells, when differentiated, comprise a cell population of neurons, astrocytes and oligodendrocytes. These cells are capable of doubling every 5-10 days, in contrast with the prior art diencephalon-derived human neural stem cells. Reported proliferation rates of diencephalon-derived human neural stem cells approximate one doubling every 30 days. See Cattaneo et al., Mol. Brain Res., 42, pp. 161-66 (1996).</p>
    <p>Any suitable tissue source may be used to derive the neural stem cells of this invention. Both allografts and autografts are contemplated for transplantation purposes.</p>
    <p>This invention also provides a novel growth media for proliferation of neural stem cells. Provided herein is a serum-free or serum-depleted culture medium for the short term and long term proliferation of neural stem cells.</p>
    <p>A number of serum-free or serum-depleted culture media have been developed due to the undesirable effects of serum which can lead to inconsistent culturing results. See, e.g., WO 95/00632 (incorporated herein by reference), and prior art medium described therein.</p>
    <p>Prior to development of the novel media described herein, neural stem cells have been cultured in serum-free media containing epidermal growth factor ("EGF") or an analog of EGF, such as amphiregulin or transforming growth factor alpha ("TGF-a"), as the mitogen for proliferation. See, e.g., WO 93/01275, WO 94/16718, both incorporated herein by reference. Further, basic fibroblast growth factor ("bFGF") has been used, either alone, or in combination with EGF, to enhance long term neural stem cell survival.</p>
    <p>The improved medium according to this invention, which contains leukemia inhibitory factor ("LIF"), markedly and unexpectedly increases the rate of proliferation of neural stem cells, particularly human neural stem cells.</p>
    <p>We have compared growth rates of the forebrain-derived stem cells described herein in the presence and absence of LIF; unexpectedly we have found that LIF dramatically increases the rate of cellular proliferation in almost all cases.</p>
    <p>The medium according to this invention comprises cell viability and cell proliferation effective amounts of the following components:</p>
    <p>(a) a standard culture medium being serum-free (containing 0-0.49% serum) or serum-depleted (containing 0.5-5.0% serum), known as a "defined" culture medium, such as Iscove's modified DulbeccO's medium ("IMDM"), RPMI, DMEM, Fischer's, alpha medium, Leibovitz's, L-15, NCTC, F-10, F-12, MEM and McCoy's;</p>
    <p>(b) a suitable carbohydrate source, such as glucose;</p>
    <p>(c) a buffer such as MOPS, HEPES or Tris, preferably HEPES;</p>
    <p>(d) a source of hormones including insulin, transferrin, progesterone, selenium, and putrescine;</p>
    <p>(e) one or more growth factors that stimulate proliferation of neural stem cells, such as EGF, bFGF, PDGF, NGF, and analogs, derivatives and/or combinations thereof, preferably EGF and bFGF in combination;</p>
    <p>(f) LIF</p>
    <p>Standard culture media typically contains a variety of essential components required for cell viability, including inorganic salts, carbohydrates, hormones, essential amino acids, vitamins, and the like. We prefer DMEM or F-12 as the standard culture medium, most preferably a 50/50 mixture of DMEM and F-12. Both media are commercially available (DMEM--Gibco 12100-046; F-12 - Gibco 21700-075). A premixed formulation is also commercially available (N2 - Gibco 17502-030). It is advantageous to provide additional glutamine, preferably at about 2 mM. It is also advantageous to provide heparin in the culture medium. Preferably, the conditions for culturing should be as close to physiological as possible. The pH of the culture medium is typically between 6-8, preferably about 7, most preferably about 7.4. Cells are typically cultured between 30-40° C., preferably between 32-38° C., most preferably between 35-37° C. Cells are preferably grown in 5% CO<sub>2</sub>. Cells are preferably grown in suspension culture.</p>
    <p>In one exemplary embodiment, the neural stem cell culture comprises the following components in the indicated concentrations:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Component        Final Concentration______________________________________50/50 mix of DMEM/F-12            0.5-2.0 X, preferably 1X  glucose 0.2-1.0%, preferably 0.6% w/v  glutamine 0.1-10 mM, preferably 2 mM  NaHCO<sub>3</sub> 0.1-10 mM, preferably 3 mM  HEPES 0.1-10 mM, preferably 5 mM  apo-human transferrin (Sigma T- 1-1000 μg/ml, preferably 100            μg/ml  2252)  human insulin (Sigma I-2767) 1-100, preferably 25 μg/ml  putrescine (Sigma P-7505) 1-500, preferably 60 μM  selenium (Sigma S-9133) 1-100, preferably 30 nM  progesterone (Sigma P-6149) 1-100, preferably 20 nM  human EGF (Gibco 13247-010) 0.2-200, preferably 20 ng/ml  human bFGF (Gibco 13256-029) 0.2-200, preferably 20 ng/ml  human LIF (R&amp;D Systems 250-L) 0.1-500, preferably 10 ng/ml  heparin (Sigma H-3149) 0.1-50, preferably 2 μg/ml  CO<sub>2</sub> preferably 5%______________________________________</pre>
    
    <p>Serum albumin may also be present in the instant culture medium--although the present medium is generally serum-depleted or serum-free (preferably serum-free), certain serum components which are chemically well defined and highly purified (&gt;95%), such as serum albumin, may be included.</p>
    <p>The human neural stem cells described herein may be cryopreserved according to routine procedures. We prefer cryopreserving about one to ten million cells in "freeze" medium which consists of proliferation medium (absent the growth factor mitogens), 10% BSA (Sigma A3059) and 7.5% DMSO. Cells are centrifuged. Growth medium is aspirated and replaced with freeze medium. Cells are resuspended gently as spheres, not as dissociated cells. Cells are slowly frozen, by, e.g., placing in a container at -80° C. Cells are thawed by swirling in a 37° C. bath, resuspended in fresh proliferation medium, and grown as usual.</p>
    <p>In another embodiment, this invention provides a differentiated cell culture containing previously unobtainable large numbers of neurons, as well as astrocytes and oligodendrocytes. In the prior art, typically the differentiated human diencephalon-derived neural stem cell cultures formed very few neurons (i.e., less than 5-10%). According to this methodology, we have routinely achieved neuron concentrations of between 20% and 35% (and much higher in other cases) in differentiated human forebrain-derived neural stem cell cultures. This is highly advantageous as it permits enrichment of the neuronal population prior to implantation in the host in disease indications where neuronal function has been impaired or lost.</p>
    <p>Further, according to the methods of this invention, we have achieved differentiated neural stem cell cultures that are highly enriched in GABA-ergic neurons. Such GABA-ergic neuron enriched cell cultures are particularly advantageous in the potential therapy of excitotoxic neurodegenerative disorders, such as Huntington's disease or epilepsy.</p>
    <p>In order to identify the cellular phenotype either during proliferation or differentiation of the neural stem cells, various cell surface or intracellular markers may be used.</p>
    <p>When the neural stem cells of this invention are proliferating as neurospheres, we contemplate using human nestin antibody as a marker to identify undifferentiated cells. The proliferating cells should show little GFAP staining and little b-tubulin staining (although some staining might be present due to diversity of cells within the spheres).</p>
    <p>When differentiated, most of the cells lose their nestin positive immunoreactivity. In particular, antibodies specific for various neuronal or glial proteins may be employed to identify the phenotypic properties of the differentiated cells. Neurons may be identified using antibodies to neuron specific enolase ("NSE"), neurofilament, tau, b-tubulin, or other known neuronal markers. Astrocytes may be identified using antibodies to glial fibrillary acidic protein ("GFAP"), or other known astrocytic markers. Oligodendrocytes may be identified using antibodies to galactocerebroside, O4, myelin basic protein ("MBP") or other known oligodendrocytic markers.</p>
    <p>It is also possible to identify cell phenotypes by identifying compounds characteristically produced by those phenotypes. For example, it is possible to identify neurons by the production of neurotransmitters such as acetylcholine, dopamine, epinephrine, norepinephrine, and the like.</p>
    <p>Specific neuronal phenotypes can be identified according to the specific products produced by those neurons. For example, GABA-ergic neurons may be identified by their production of glutamic acid decarboxylase ("GAD") or GABA. Dopaminergic neurons may be identified by their production of dopa decarboxylase ("DDC"), dopamine or tyrosine hydroxylase ("TH"). Cholinergic neurons may be identified by their production of choline acetyltransferase ("ChAT"). Hippocampal neurons may be identified by staining with NeuN. It will be appreciated that any suitable known marker for identifying specific neuronal phenotypes may be used.</p>
    <p>The human neural stem cells described herein can be genetically engineered or modified according to known methodology.</p>
    <p>A gene of interest (i.e., a gene that encodes a biologically active molecule) can be inserted into a cloning site of a suitable expression vector by using standard techniques. These techniques are well known to those skilled in the art. See, e.g., WO 94/16718, incorporated herein by reference.</p>
    <p>The expression vector containing the gene of interest may then be used to transfect the desired cell line. Standard transfection techniques such as calcium phosphate co-precipitation, DEAE-dextran transfection, electroporation, biolistics, or viral transfection may be utilized. Commercially available mammalian transfection kits may be purchased from e.g., Stratagene. Human adenoviral transfection may be accomplished as described in Berg et al. Exp. Cell Res., 192, pp. (1991). Similarly, lipofectamine-based transfection may be accomplished as described in Cattaneo, Mol. Brain Res., 42, pp. 161-66 (1996).</p>
    <p>A wide variety of host/expression vector combinations may be used to express a gene encoding a biologically active molecule of interest. See, e.g., U.S. Pat. No. 5,545,723, herein incorporated by reference, for suitable cell-based production expression vectors.</p>
    <p>Increased expression of the biologically active molecule can be achieved by increasing or amplifying the transgene copy number using amplification methods well known in the art. Such amplification methods include, e.g., DHFR amplification (see, e.g., Kaufman et al., U.S. Pat. No. 4,470,461) or glutamine synthetase ("GS") amplification (see, e.g., U.S. Pat. No. 5,122,464, and European published application EP 338,841), all herein incorporated by reference.</p>
    <p>The neural stem cells described herein, and their differentiated progeny may be immortalized or conditionally immortalized using known techniques. We prefer conditional immortalization of stem cells, and most preferably conditional immortalization of their differentiated progeny. Among the conditional immortalization techniques contemplated are Tet-conditional immortalization (see WO 96/31242, incorporated herein by reference), and Mx-1 conditional immortalization (see WO 96/02646, incorporated herein by reference).</p>
    <p>This invention also provides methods for differentiating neural stem cells to yield cell cultures enriched with neurons to a degree previously unobtainable. According to one protocol, the proliferating neurospheres are induced to differentiate by removal of the growth factor mitogens and LIF, and provision of 1% serum, a substrate and a source of ionic charges (e.g., glass cover slip covered with poly-ornithine or extracellular matrix components). The preferred base medium for this differentiation protocol, excepting the growth factor mitogens and LIF, is otherwise the same as the proliferation medium. This differentiation protocol produces a cell culture enriched in neurons. According to this protocol, we have routinely achieved neuron concentrations of between 20% and 35% in differentiated human forebrain-derived neural stem cell cultures.</p>
    <p>According to a second protocol, the proliferating neurospheres are induced to differentiate by removal of the growth factor mitogens, and provision of 1% serum, a substrate and a source of ionic charges (e.g., glass cover slip covered with poly-ornithine or extracellular matrix components), as well as a mixture of growth factors including PDGF, CNTF, IGF-1, LIF, forskolin, T-3 and NT-3. The cocktail of growth factors may be added at the same time as the neurospheres are removed from the proliferation medium, or may be added to the proliferation medium and the cells pre-incubated with the mixture prior to removal from the mitogens. This protocol produces a cell culture highly enriched in neurons and enriched in oligodendrocytes. According to this protocol, we have routinely achieved neuron concentrations of higher than 35% in differentiated human forebrain-derived neural stem cell cultures.</p>
    <p>The human stem cells of this invention have numerous uses, including for drug screening, diagnostics, genomics and transplantation.</p>
    <p>The cells of this invention may be transplanted "naked" into patients according to conventional techniques, into the CNS, as described for example, in U.S. Pat. Nos. 5,082,670 and 5,618,531, each incorporated herein by reference, or into any other suitable site in the body.</p>
    <p>In one embodiment, the human stem cells are transplanted directly into the CNS. Parenchymal and intrathecal sites are contemplated. It will be appreciated that the exact location in the CNS will vary according to the disease state. According to one aspect of this invention, provided herein is methodology for improving the viability of transplanted human neural stem cells. In particular, we have discovered that graft viability improves if the transplanted neural stem cells are allowed to aggregate, or to form neurospheres prior to implantation, as compared to transplantation of dissociated single cell suspensions. We prefer transplanting small sized neurospheres, approximately 10-500 μm in diameter, preferably 40-50 μm in diameter. Alternatively, we prefer spheres containing about 5-100, preferably 5-20 cells per sphere. We contemplate transplanting at a density of about 10,000-1,000,000 cells per μl, preferably 25,000-500,000 cells per μl.</p>
    <p>The cells may also be encapsulated and used to deliver biologically active molecules, according to known encapsulation technologies, including microencapsulation (see, e.g., U.S. Pat. Nos. 4,352,883; 4,353,888; and 5,084,350, herein incorporated by reference), (b) macroencapsulation (see, e.g., U.S. Pat. Nos. 5,284,761, 5,158,881, 4,976,859 and 4,968,733 and published PCT patent applications W092/19195, WO 95/05452, each incorporated herein by reference).</p>
    <p>If the human neural stem cells are encapsulated, we prefer macroencapsulation, as described in U.S. Pat. Nos. 5,284,761; 5,158,881; 4,976,859; 4,968,733; 5,800,828 and published PCT patent application WO 95/05452, each incorporated herein by reference. Cell number in the devices can be varied; preferably each device contains between 10<sup>3</sup> -10<sup>9</sup> cells, most preferably 10<sup>5</sup> to 10<sup>7</sup> cells. A large number of macroencapsulation devices may be implanted in the patient; we prefer between one to 10 devices.</p>
    <p>In addition, we also contemplate "naked" transplantation of human stem cells in combination with a capsular device wherein the capsular device secretes a biologically active molecule that is therapeutically effective in the patient or that produces a biologically active molecule that has a growth or trophic effect on the transplanted neural stem cells, or that induces differentiation of the neural stem cells towards a particular phenotypic lineage.</p>
    <p>The cells and methods of this invention may be useful in the treatment of various neurodegenerative diseases and other disorders. It is contemplated that the cells will replace diseased, damaged or lost tissue in the host. Alternatively, the transplanted tissue may augment the function of the endogenous affected host tissue. The transplanted neural stem cells may also be genetically modified to provide a biologically active molecule that is therapeutically effective.</p>
    <p>Excitotoxicity has been implicated in a variety of pathological conditions including epilepsy, stroke, ischemia, and neurodegenerative diseases such as Huntington's disease, Parkinson's disease and Alzheimer's disease. Accordingly, neural stem cells may provide one means of preventing or replacing the cell loss and associated behavioral abnormalities of these disorders.</p>
    <p>Huntington's disease (HD) is an autosomal dominant neurodegenerative disease characterized by a relentlessly progressive movement disorder with devastating psychiatric and cognitive deterioration. HD is associated with a consistent and severe atrophy of the neostriatum which is related to a marked loss of the GABAergic medium-sized spiny projection neurons, the major output neurons of the striatum. Intrastriatal injections of excitotoxins such as quinolinic acid (QA) mimic the pattern of selective neuronal vulnerability seen in HD. QA lesions result in motor and cognitive deficits which are among the major symptoms seen in HD. Thus, intrastriatal injections of QA have become a useful model of HD and can serve to evaluate novel therapeutic strategies aimed at preventing, attenuating, or reversing neuroanatomical and behavioral changes associated with HD. Because GABA-ergic neurons are characteristically lost in Huntington's disease, we contemplate treatment of Huntington's patients by transplantation of cell cultures enriched in GABA-ergic neurons derived according to the methods of this invention.</p>
    <p>Epilepsy is also associated with excitotoxicity. Accordingly, GABA-ergic neurons derived according to this invention are contemplated for transplantation into patients suffering from epilepsy.</p>
    <p>We also contemplate use of the cells of this invention in the treatment of various demyelinating and dysmyelinating disorders, such as Pelizaeus-Merzbacher disease, multiple sclerosis, various leukodystrophies, post-traumatic demyelination, and cerebrovascular (CVS) accidents, as well as various neuritis and neuropathies, particularly of the eye. We contemplate using cell cultures enriched in oligodendrocytes or oligodendrocyte precursor or progenitors, such cultures prepared and transplanted according to this invention to promote remyelination of demyelinated areas in the host.</p>
    <p>We also contemplate use of the cells of this invention in the treatment of various acute and chronic pains, as well as for certain nerve regeneration applications (such as spinal cord injury). We also contemplate use of human stem cells for use in sparing or sprouting of photoreceptors in the eye.</p>
    <p>The cells and methods of this invention are intended for use in a mammalian host, recipient, patient, subject or individual, preferably a primate, most preferably a human.</p>
    <p>The following examples are provided for illustrative purposes only, and are not intended to be limiting.</p>
    <heading>EXAMPLES</heading> <heading>Example 1</heading> <heading>Media for Proliferating Neural Stem Cells</heading> <p>Proliferation medium was prepared with the following components in the indicated concentrations:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Component            Final Concentration______________________________________50/50 mix of DMEM/F-12                1Xglucose              0.6%      w/v  glutamine 2 mM  NaHCO<sub>3</sub> 3 mM  HEPES 5 mM  apo-human transferrin (Sigma T-2252) 100 μg/ml  human insulin (Sigma I-2767) 25 μg/ml  putrescine (Sigma P-7505) 60 μM  selenium (Sigma S-9133) 30 nM  progesterone (Sigma P-6149) 20 nM  human EGF (Gibco 13247-010) 20 ng/ml  human bFGF (Gibco 13256-029) 20 ng/ml  human LIF (R&amp;D Systems 250-L) 10 ng/ml  heparin (Sigma H-3149) 2 μg/ml______________________________________</pre>
    
    <heading>Example 2</heading> <heading>Isolation of Human CNS Neural Stem Cells</heading> <p>Sample tissue from human embryonic forebrain was collected and dissected in Sweden and kindly provided by Huddinje Sjukhus. Blood samples from the donors were sent for viral testing. Dissections were performed in saline and the selected tissue was placed directly into proliferation medium (as described in Example 1). Tissue was stored at 4° C. until dissociated. The tissue was dissociated using a standard glass homogenizer, without the presence of any digesting enzymes. The dissociated cells were counted and seeded into flasks containing proliferation medium. After 5-7 days, the contents of the flasks are centrifuged at 1000 rpm for 2 min. The supernatant was aspirated and the pellet resuspended in 200 μl of proliferation medium. The cell clusters were triturated using a P200 pipetman about 100 times to break up the clusters. Cells were reseeded at 75,000-100,000 cells/ml into proliferation medium. Cells were passaged every 6-21 days depending upon the mitogens used and the seeding density. Typically these cells incorporate BrdU, indicative of cell proliferation. For T75 flask cultures (initial volume 20 ml), cells are "fed" 3 times weekly by addition of 5 ml of proliferation medium. We prefer Nunc flasks for culturing.</p>
    <heading>Nestin Staining for Proliferating Neurospheres</heading> <p>We stained for nestin (a measure of proliferating neurospheres) as follows. Cells were fixed for 20 min at room temperature with 4% paraformaldehyde. Cells were washed twice for 5 min with 0.1 M PBS, pH 7.4. Cells were permeabilized for 2 min with 100% EtOH. The cells were then washed twice for 5 min with 0.1 M PBS. Cell preparations were blocked for 1 hr at room temperature in 5% normal goat serum ("NGS") diluted in 0.1 M PBS, pH 7.4 and 1% Triton X-100 (Sigma X-100) for 1 hr at room temperature with gentle shaking. Cells were incubated with primary antibodies to human nestin (from Dr. Lars Wahlberg, Karolinska, Sweden, rabbit polyclonal used at 1:500) diluted in 1% NGS and 1% Triton X-100 for 2 hr at room temperature. Preparations were then washed twice for 5 min with 0.1 M PBS. Cells were incubated with secondary antibodies (pool of GAM/FITC used at 1:128, Sigma F-0257; GAR/TRITC used at 1:80, Sigma T-5268) diluted in 1% NGS and 1% Triton X-100 for 30 min at room temperature in the dark. Preparations are washed twice for 5 min with 0.1 M PBS in the dark. Preparations are mounted onto slides face down with mounting medium (Vectashield Mounting Medium, Vector Labs., H-1000) and stored at 4° C.</p>
    <p>FIG. 1 shows a picture of proliferating spheres (here called "neurospheres") of human forebrain derived neural stem cells. We evaluated proliferation of 4 lines of human forebrain derived neural stem cells in proliferation medium as described above with LIF present of absent.</p>
    <p>As FIG. 2 shows, in three of the four lines (6.5 Fbr, 9 Fbr, and 10.5 FBr), LIF significantly increased the rate of cell proliferation. The effect of LIF was most pronounced after about 60 days in vitro.</p>
    <p>We also evaluated the effect of bFGF on the rate of proliferation of human forebrain-derived neural stem cells. As FIG. 3 shows, in the presence of bFGF, the stem cells proliferation was significantly enhanced.</p>
    <heading>Example 3</heading> <heading>Differentiation of Human Neural Stem Cells</heading> <p>In a first differentiation protocol, the proliferating neurospheres were induced to differentiate by removal of the growth factor mitogens and LIF, and provision of 1% serum, a substrate and a source of ionic charges(e.g., glass cover slip covered with poly-ornithine).</p>
    <p>The staining protocol for neurons, astrocytes and oligodendrocytes was as follows:</p>
    <heading>β-Tubulin Staining for Neurons</heading> <p>Cells were fixed for 20 min at room temperature with 4% paraformaldehyde. Cells were washed twice for 5 min with 0.1 M PBS, pH 7.4. Cells were permeabilized for 2 min with 100% EtOH. The cells were then washed twice for 5 min with 0.1 M PBS. Cell preparations were blocked for 1 hr at room temperature in 5% normal goat serum ("NGS") diluted in 0.1 M PBS, pH 7.4. Cells were incubated with primary antibodies to b-tubulin (Sigma T-8660, mouse monoclonal; used at 1: 1,000) diluted in 1% NGS for 2 hr at room temperature. Preparations were then washed twice for 5 min with 0.1 M PBS. Cells were incubated with secondary antibodies (pool of GAM/FITC used at 1:128, Sigma F-0257; GAR/TRITC used at 1:80, Sigma T-5268) diluted in 1% NGS for 30 min at room temperature in the dark. Preparations are washed twice for 5 min with 0.1 M PBS in the dark. Preparations are mounted onto slides face down with mounting medium (Vectashield Mounting Medium, Vector Labs., H1000) and stored at 4° C.</p>
    <p>In some instances we also stain with DAPI (a nuclear stain), as follows. Coverslips prepared as above are washed with DAPI solution (diluted 1:1000 in 100% MeOH, Boehringer Mannheim, # 236 276). Coverslips are incubated in DAPI solution for 15 min at 37° C.</p>
    <heading>O4 Staining for Oligodendrocvtes</heading> <p>Cells were fixed for 10 min at room temperature with 4% paraformaldehyde. Cells were washed three times for 5 min with 0.1 M PBS, pH 7.4. Cell preparations were blocked for 1 hr at room temperature in 5% normal goat serum ("NGS") diluted in 0.1 M PBS, pH 7.4. Cells were incubated with primary antibodies to O4 (Boehringer Mannheim # 1518 925, mouse monoclonal; used at 1:25) diluted in 1% NGS for 2 hr at room temperature. Preparations were then washed twice for 5 min with 0.1 M PBS. Cells were incubated with secondary antibodies, and further processed as described above for b-tubulin.</p>
    <heading>GFAP Staining for Astrocytes</heading> <p>Cells were fixed for 20 min at room temperature with 4% paraformaldehyde. Cells were washed twice for 5 min with 0.1 M PBS, pH 7.4. Cells were permeabilized for 2 min with 100% EtOH. The cells were then washed twice for 5 min with 0.1 M PBS. Cell preparations were blocked for 1 hr at room temperature in 5% normal goat serum ("NGS") diluted in 0.1 M PBS, pH 7.4. Cells were incubated with primary antibodies to GFAP (DAKO Z 334, rabbit polyclonal; used at 1:500) diluted in 1% NGS for 2 hr at room temperature. Preparations were then washed twice for 5 min with 0.1 M PBS. Cells were incubated with secondary antibodies, and further processed as described above for b-tubulin.</p>
    <p>This differentiation protocol produced cell cultures enriched in neurons as follows:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________            % GFAP   % b-tubulin                             % of neurons that  Cell Line Passage Positive positive are GABA positive______________________________________6.5  FBr    5        15     37      20  9 FBr 7 52 20 35  10.5 FBr 5 50 28 50______________________________________</pre>
    
    <p>We also evaluated the ability of a single cell line to differentiate consistently as the culture aged (i.e., at different passages), using the above differentiation protocol. The data are as follows:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________           % GFAP    % b-tubulin                             % of neurons that  Cell Line Passage Positive positive are GABA positive______________________________________9 FBr  7        53        20.4    ND  9 FBr 9 ND 20.3 34.5  9 FBr 15   62 17.9 37.9______________________________________</pre>
    
    <p>We conclude from these data that cells will follow reproducible differentiation patterns irrespective of passage number or culture age.</p>
    <heading>Example 4</heading> <heading>Differentiation of Human Neural Stem Cells</heading> <p>In a second differentiation protocol, the proliferating neurospheres were induced to differentiate by removal of the growth factor mitogens and LIF, and provision of 1% serum, a substrate (e.g., glass cover slip or extracellular matrix components), a source of ionic charges (e.g., poly-ornithine) as well as a mixture of growth factors including 10 ng/ml PDGF A/B, 10 ng/ml CNTF, 10 ng/ml IGF-1, 10 μM forskolin, 30 ng/ml T3, 10 ng/ml LIF and 1 ng/ml NT-3. This differentiation protocol produced cell cultures highly enriched in neurons (i.e., greater than 35% of the differentiated cell culture) and enriched in oligodendrocytes.</p>
    <heading>Example 5</heading> <heading>Genetic Modification</heading> <p>We have conditionally immortalized a glioblast cell line derived from the human neural stem cells described herein, using the Mx-1 system described in WO 96/02646. In the Mx-1 system, the Mx-1 promoter drives expression of the SV40 large T antigen. The Mx-1 promoter is induced by interferon. When induced, large T is expressed, and quiescent cells proliferate.</p>
    <p>Human glioblasts were derived from human forebrain neural stem cells as follows. Proliferating human neurospheres were removed from proliferation medium and plated onto poly-ornithine plastic (24 well plate) in a mixture of N2 with the mitogens EGF, bFGF and LIF, as well as 0.5% FBS. 0.5 ml of N2 medium and 1% FBS was added. The cells were incubated overnight. The cells were then transfected with p318 (a plasmid containing the Mx-1 promoter operably linked to the SV 40 large T antigen) using Invitrogen lipid kit (lipids 4 and 6). The transfection solution contained 6 μI/ml of lipid and 4 μl/ml DNA in optiMEM medium. The cells were incubated in transfection solution for 5 hours. The transfection solution was removed and cells placed into N2 and 1% FBS and 500 U/ml A/D interferon. The cells were fed twice a week. After ten weeks cells were assayed for large T antigen expression. The cells showed robust T antigen staining at this time. As FIG. 4 shows, cell number was higher in the presence of interferon than in the absence of interferon.</p>
    <p>Large T expression was monitored using immunocytochemistry as follows. Cells were fixed for 20 min at room temperature with 4% paraformaldehyde. Cells were washed twice for 5 min with 0.1 M PBS, pH 7.4. Cells were permeabilized for 2 min with 100% EtOH. The cells were then washed twice for 5 min with 0.1 M PBS. Cell preparations were blocked for 1 hr at room temperature in 5% normal goat serum ("NGS") diluted in 0.1 M PBS, pH 7.4. Cells were incubated with primary antibodies to large T antigen (used at 1:10) diluted in 1% NGS for 2 hr at room temperature. We prepared antibody to large T antigen in house by culturing PAB 149 cells and obtaining the conditioned medium. Preparations were then washed twice for 5 min with 0.1 M PBS. Cells were incubated with secondary antibodies (goat-anti-mouse biotinylated at 1:500 from Vector Laboratories, Vectastain Elite ABC mouse IgG kit, PK-6102) diluted in 1% NGS for 30 min at room temperature. Preparations are washed twice for 5 min with 0.1 M PBS. Preparations are incubated in ABC reagent diluted 1:500 in 0.1 M PBS, pH 7.4 for 30 min at room temperature. Cells are washed twice for 5 min in 0.1 M PBS, pH 7.4, then washed twice for 5 min in 0.1 M Tris, pH 7.6. Cells are incubated in DAB (nickel intensification) for 5 min at room temperature. The DAB solution is removed, and cells are washed three to five times with dH20. Cells are stored in 50% glycerol/50% 0.1 M PBS, pH 7.4.</p>
    <heading>Example 6</heading> <heading>Encapsulation</heading> <p>If the human neural stem cells are encapsulated, then the following procedure may be used:</p>
    <p>The hollow fibers are fabricated from a polyether sulfone (PES) with an outside diameter of 720 m and a wall thickness of a 100 m (AKZO-Nobel Wuppertal, Germany). These fibers are described in U.S. Pat. Nos. 4,976,859 and 4,968,733, herein incorporated by reference. The fiber may be chosen for its molecular weight cutoff. We sometimes use a PES#5 membrane which has a MWCO of about 280 kd. In other studies we use a PES#8 membrane which has a MWCO of about 90 kd.</p>
    <p>The devices typically comprise:</p>
    <p>1) a semipermeable poly (ether sulfone) hollow fiber membrane fabricated by AKZO Nobel Faser AG;</p>
    <p>2) a hub membrane segment;</p>
    <p>3) a light cured methacrylate (LCM) resin leading end; and</p>
    <p>4) a silicone tether.</p>
    <p>The semipermeable membrane used typically has the following characteristics:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">______________________________________Internal Diameter 500 + 30 m  Wall Thickness 100 + 15 m  Force at Break 100 + 15 cN  Elongation at Break 44 + 10%  Hydraulic Permeability 63 + 8 (ml/min m<sup>2</sup> mmHg)  nMWCO (dextrans) 280 + 20 kd______________________________________</pre>
    
    <p>The components of the device are commercially available. The LCM glue is available from Ablestik Laboratories (Newark, Del.); Luxtrak Adhesives LCM23 and LCM24). The tether material is available from Specialty Silicone Fabricators (Robles, Calif.). The tether dimensions are 0.79 mm OD×0.43 mm ID×length 202 mm. The morphology of the device is as follows: The inner surface has a permselective skin. The wall has an open cell foam structure. The outer surface has an open structure, with pores up to 1.5 m occupying 30+5% of the outer surface.</p>
    <p>Fiber material is first cut into 5 cm long segments and the distal extremity of each segment sealed with a photopolymerized acrylic glue (LCM-25, ICI). Following sterilization with ethylene oxide and outgassing, the fiber segments are loaded with a suspension of between 10<sup>4</sup> -10<sup>7</sup> cells, either in a liquid medium, or a hydrogel matrix (e.g., a collagen solution (Zyderm®), alginate, agarose or chitosan) via a Hamilton syringe and a 25 gauge needle through an attached injection port. The proximal end of the capsule is sealed with the same acrylic glue. The volume of the device contemplated in the human studies is approximately 15-18 1.</p>
    <p>A silicone tether (Specialty Silicone Fabrication, Taunton, Mass.) (ID: 690 m; OD: 1.25 mm) is placed over the proximal end of the fiber allowing easy manipulation and retrieval of the device.</p>
    <heading>Example 8</heading> <heading>Transplantation of Neural Stem Cells</heading> <p>We have transplanted human neural stem cells into rat brain and assessed graft viability, integration, phenotypic fate of the grafted cells, as well as behavioral changes associated with the grafted cells in lesioned animals.</p>
    <p>Transplantation was performed according to standard techniques. Adult rats were anesthetized with sodium pentobarbitol (45 mg/kg, i.p.) And positioned in a Kopf stereotaxic instrument. A midline incision was made in the scalp and a hole drilled for the injection of cells. Rats received implants of unmodified, undifferentiated human neural stem cells into the left striatum using a glass capillary attached to a 10 μl Hamilton syringe. Each animal received a total of about 250,000-500,000 cells in a total volume of 2 μl. Cells were transplanted 1-2 days after passaging and the cell suspension was made up of undifferentiated stem cell clusters of 5-20 cells. Following implantation, the skin was sutured closed.</p>
    <p>Animals were behaviorally tested and then sacrificed for histological analysis.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4753635">US4753635</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 23, 1986</td><td class="patent-data-table-td patent-date-value">Jun 28, 1988</td><td class="patent-data-table-td ">Jacqueline Sagen</td><td class="patent-data-table-td ">Inducing analgesia by implantation of cells releasing neuroactive substances</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4980174">US4980174</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 23, 1988</td><td class="patent-data-table-td patent-date-value">Dec 25, 1990</td><td class="patent-data-table-td ">Jacqueline Sagen</td><td class="patent-data-table-td ">Implanting monoamine-producing living cells in central nervous system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5082670">US5082670</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 15, 1988</td><td class="patent-data-table-td patent-date-value">Jan 21, 1992</td><td class="patent-data-table-td ">The Regents Of The University Of California</td><td class="patent-data-table-td ">Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5175103">US5175103</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 21, 1991</td><td class="patent-data-table-td patent-date-value">Dec 29, 1992</td><td class="patent-data-table-td ">Trustees Of University Of Pennsylvania</td><td class="patent-data-table-td ">Preparation of pure cultures of post-mitotic human neurons</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5411883">US5411883</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 12, 1992</td><td class="patent-data-table-td patent-date-value">May 2, 1995</td><td class="patent-data-table-td ">Somatix Therapy Corporation</td><td class="patent-data-table-td ">Proliferated neuron progenitor cell product and process</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5580777">US5580777</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 27, 1994</td><td class="patent-data-table-td patent-date-value">Dec 3, 1996</td><td class="patent-data-table-td ">Amrad Corporation Limited</td><td class="patent-data-table-td ">Generation of neural precursor cell lines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5612211">US5612211</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 15, 1993</td><td class="patent-data-table-td patent-date-value">Mar 18, 1997</td><td class="patent-data-table-td ">New York University</td><td class="patent-data-table-td ">Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5639618">US5639618</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 13, 1994</td><td class="patent-data-table-td patent-date-value">Jun 17, 1997</td><td class="patent-data-table-td ">Plurion, Inc.</td><td class="patent-data-table-td ">Method of isolating a lineage specific stem cell in vitro</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5672499">US5672499</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Sep 30, 1997</td><td class="patent-data-table-td ">California Institute Of Technology</td><td class="patent-data-table-td ">Genetic engineering; fusion gene into cell</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5688692">US5688692</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 11, 1993</td><td class="patent-data-table-td patent-date-value">Nov 18, 1997</td><td class="patent-data-table-td ">Ludwig Institute For Cancer Research</td><td class="patent-data-table-td ">Dna sequences and cell culture</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5750376">US5750376</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">May 12, 1998</td><td class="patent-data-table-td ">Neurospheres Holdings Ltd.</td><td class="patent-data-table-td ">In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5753506">US5753506</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 25, 1996</td><td class="patent-data-table-td patent-date-value">May 19, 1998</td><td class="patent-data-table-td ">Cns Stem Cell Technology, Inc.</td><td class="patent-data-table-td ">Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1989003872A1?cl=en">WO1989003872A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 28, 1988</td><td class="patent-data-table-td patent-date-value">May 5, 1989</td><td class="patent-data-table-td ">Amrad Corp Ltd</td><td class="patent-data-table-td ">Generation of neural precursor cell lines</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1990006757A1?cl=en">WO1990006757A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 12, 1989</td><td class="patent-data-table-td patent-date-value">Jun 28, 1990</td><td class="patent-data-table-td ">Univ California</td><td class="patent-data-table-td ">Grafting genetically modified cells to treat diseases of the central nervous system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1991002003A1?cl=en">WO1991002003A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 30, 1990</td><td class="patent-data-table-td patent-date-value">Feb 21, 1991</td><td class="patent-data-table-td ">Univ Texas</td><td class="patent-data-table-td ">Methods and compositions; purified preparation of neural progenitor regulatory factor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1991009936A1?cl=en">WO1991009936A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 21, 1990</td><td class="patent-data-table-td patent-date-value">Jul 11, 1991</td><td class="patent-data-table-td ">Hana Biolog Inc</td><td class="patent-data-table-td ">Proliferated neuron progenitor cell product and process</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1991017141A2?cl=en">WO1991017141A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 29, 1991</td><td class="patent-data-table-td patent-date-value">Oct 27, 1991</td><td class="patent-data-table-td ">Schering Corp</td><td class="patent-data-table-td ">Diastereoselective process for preparing n-substituted amino acids and derivatives</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993001275A1?cl=en">WO1993001275A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 7, 1992</td><td class="patent-data-table-td patent-date-value">Jan 21, 1993</td><td class="patent-data-table-td ">Samuel Weiss</td><td class="patent-data-table-td ">NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993009802A2?cl=en">WO1993009802A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 20, 1992</td><td class="patent-data-table-td patent-date-value">May 27, 1993</td><td class="patent-data-table-td ">Auckland Uniservices Ltd</td><td class="patent-data-table-td ">Tgf-beta to improve neural outcome</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1994009119A1?cl=en">WO1994009119A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 15, 1993</td><td class="patent-data-table-td patent-date-value">Apr 28, 1994</td><td class="patent-data-table-td ">Neurospheres Ltd</td><td class="patent-data-table-td ">Remyelination using neural stem cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1994010292A1?cl=en">WO1994010292A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 27, 1993</td><td class="patent-data-table-td patent-date-value">May 11, 1994</td><td class="patent-data-table-td ">Neurospheres Ltd</td><td class="patent-data-table-td ">Biological factors and neural stem cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1994016718A1?cl=en">WO1994016718A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 28, 1994</td><td class="patent-data-table-td patent-date-value">Aug 4, 1994</td><td class="patent-data-table-td ">Neurospheres Ltd</td><td class="patent-data-table-td ">Genetic modification of neural stem cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1995000632A1?cl=en">WO1995000632A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 17, 1994</td><td class="patent-data-table-td patent-date-value">Jan 5, 1995</td><td class="patent-data-table-td ">Amgen Inc</td><td class="patent-data-table-td ">Medium for long-term proliferation and development of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1996015226A1?cl=en">WO1996015226A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 14, 1995</td><td class="patent-data-table-td patent-date-value">May 23, 1996</td><td class="patent-data-table-td ">Neurospheres Holdings Ltd</td><td class="patent-data-table-td ">Regulation of neural stem cell proliferation</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Anchan et al., "<a href='http://scholar.google.com/scholar?q="EGF+and+TGF-.%E2%88%9D.+Stimulate+Retinal+Neuroepithelial+Cell+Proliferation+in+Vitro%2C"'>EGF and TGF-.∝. Stimulate Retinal Neuroepithelial Cell Proliferation in Vitro,</a>" Neuron, 6(6):923-936 (1991).</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Anchan et al., EGF and TGF . . Stimulate Retinal Neuroepithelial Cell Proliferation in Vitro, Neuron, 6(6):923 936 (1991).</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Andres "<a href='http://scholar.google.com/scholar?q="Removal+and+reimplantation+of+the+parietal+cortex+of+mice+during+the+first+nine+days+of+life%3A+consequences+for+the+barrelfield"'>Removal and reimplantation of the parietal cortex of mice during the first nine days of life: consequences for the barrelfield</a>" Journal of Neural Transplantation 1(1):11-12 (1989) (abstract).</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Andres Removal and reimplantation of the parietal cortex of mice during the first nine days of life: consequences for the barrelfield Journal of Neural Transplantation 1(1):11 12 (1989) (abstract).</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Blakemore &amp; Crang., "<a href='http://scholar.google.com/scholar?q="Extensive+Oligodendrocyte+Remyelination+Following+Injection+of+Cultured+Central+Nervous+System%2C"'>Extensive Oligodendrocyte Remyelination Following Injection of Cultured Central Nervous System,</a>" Developmental Neuroscience, 10:1-11 (1988).</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Blakemore &amp; Crang., Extensive Oligodendrocyte Remyelination Following Injection of Cultured Central Nervous System, Developmental Neuroscience, 10:1 11 (1988).</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bossart et al., "<a href='http://scholar.google.com/scholar?q="Epidermal+growth+factor+stimulates+colony+formation+and+non-neuronal+marker+protein+expression+by+human+neuroblastoma+in+methylcellulose+culture"'>Epidermal growth factor stimulates colony formation and non-neuronal marker protein expression by human neuroblastoma in methylcellulose culture</a>", Anticancer Res. 9: 1496-1504, (1989).</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bossart et al., Epidermal growth factor stimulates colony formation and non neuronal marker protein expression by human neuroblastoma in methylcellulose culture , Anticancer Res. 9: 1496 1504, (1989).</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Calof et al., "<a href='http://scholar.google.com/scholar?q="Analysis+of+Neurogenesis+in+a+Mammalian+Neuroepithelium%3A+Proliferation+and+Differentiation+of+an+Olfactory+Neuron+Precursor+in+Vitro%2C"'>Analysis of Neurogenesis in a Mammalian Neuroepithelium: Proliferation and Differentiation of an Olfactory Neuron Precursor in Vitro,</a>" Neuron, 3:115-127 (1989).</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Calof et al., "<a href='http://scholar.google.com/scholar?q="Regulation+of+Neurogenesis+and+neuronal+differentiation+in+primary+and+immortalized+cells+from+Mouse+olfactory+epithellum"'>Regulation of Neurogenesis and neuronal differentiation in primary and immortalized cells from Mouse olfactory epithellum</a>", J. Cell Biol. 109(4 part 2): 57A, (1989).</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Calof et al., Analysis of Neurogenesis in a Mammalian Neuroepithelium: Proliferation and Differentiation of an Olfactory Neuron Precursor in Vitro, Neuron, 3:115 127 (1989).</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Calof et al., Regulation of Neurogenesis and neuronal differentiation in primary and immortalized cells from Mouse olfactory epithellum , J. Cell Biol. 109(4 part 2): 57A, (1989).</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Cattaneo and McKay., "<a href='http://scholar.google.com/scholar?q="Proliferation+and+differentiation+of+neuronal+stem+cells+regulated+by+nerve+growth+factor%2C"'>Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor,</a>" Nature, 347:762-765 (1990).</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Cattaneo and McKay., Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor, Nature, 347:762 765 (1990).</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Cattaneo et al., "<a href='http://scholar.google.com/scholar?q="Non-virally+mediated+gene+transfer+into+human+central+nervous+system+precursor+cells"'>Non-virally mediated gene transfer into human central nervous system precursor cells</a>", Mol. Brain Res., 42: 161-66, (1996).</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Cattaneo et al., Non virally mediated gene transfer into human central nervous system precursor cells , Mol. Brain Res., 42: 161 66, (1996).</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Cepko et al., "<a href='http://scholar.google.com/scholar?q="Immortalization+of+neural+cells+via+retrovirus-mediated+oncogene+transduction%2C"'>Immortalization of neural cells via retrovirus-mediated oncogene transduction,</a>" Ann. Rev. Neurosci., 12:47-65 (1989).</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Cepko et al., Immortalization of neural cells via retrovirus mediated oncogene transduction, Ann. Rev. Neurosci., 12:47 65 (1989).</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Drago et al., "<a href='http://scholar.google.com/scholar?q="Fibroblast+growth+factor-mediated+proliferation+of+central+nervous+system+precursors+depends+on+endogenous+production+of+insulin-like+growth+factor+I"'>Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I</a>", Proc. Natl. Acad. Sci. USA 88(6): 2199-21203, (1991).</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Drago et al., Fibroblast growth factor mediated proliferation of central nervous system precursors depends on endogenous production of insulin like growth factor I , Proc. Natl. Acad. Sci. USA 88(6): 2199 21203, (1991).</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Federoff et al. "<a href='http://scholar.google.com/scholar?q="Expression+of+nerve+growth+factor+in+vivo+from+a+defective+herpes+simplex+virus+1+vector+prevents+effects+of+axotomy+on+sympathetic+ganglia"'>Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia</a>" (Proc. Natl. Acad. Sci. USA 89(5): 1636-1640, 1992).</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Federoff et al. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia ( Proc. Natl. Acad. Sci. USA 89(5): 1636 1640, 1992).</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Franklin et al., "<a href='http://scholar.google.com/scholar?q="Transplanted+type-1+astrocyystes+facilities+repair+of+demyelinating+lesions+by+host+oligodendrycytes+in+adult+rat+spinal+cord"'>Transplanted type-1 astrocyystes facilities repair of demyelinating lesions by host oligodendrycytes in adult rat spinal cord</a>", Neuropathol Appl Neurobiol 17(3), 244, (1991).</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Franklin et al., Transplanted type 1 astrocyystes facilities repair of demyelinating lesions by host oligodendrycytes in adult rat spinal cord , Neuropathol Appl Neurobiol 17(3), 244, (1991).</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Frederiksen et al., "<a href='http://scholar.google.com/scholar?q="Immortalization+of+precursor+cells+from+the+mammalian+CNS%2C"'>Immortalization of precursor cells from the mammalian CNS,</a>" Neuron, 1:439-448 (1988).</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Frederiksen et al., "<a href='http://scholar.google.com/scholar?q="Proliferation+and+differentiation+of+rat+neuroepithelial+precursor+cells+in+vivo%2C"'>Proliferation and differentiation of rat neuroepithelial precursor cells in vivo,</a>" The Journal of Neuroscience 8(4): 1144-1151 (1988).</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Frederiksen et al., Immortalization of precursor cells from the mammalian CNS, Neuron, 1:439 448 (1988).</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Frederiksen et al., Proliferation and differentiation of rat neuroepithelial precursor cells in vivo, The Journal of Neuroscience 8(4): 1144 1151 (1988).</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Geller et al., "<a href='http://scholar.google.com/scholar?q="A+Defective+HSV-1+vector+expresses+Escherichia+coli+.%CE%B2.-galactosidase+in+cultured+peripheral+neurons%2C"'>A Defective HSV-1 vector expresses Escherichia coli .β.-galactosidase in cultured peripheral neurons,</a>" Science, 241:1667-1669 (1988).</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Geller et al., A Defective HSV 1 vector expresses Escherichia coli . . galactosidase in cultured peripheral neurons, Science, 241:1667 1669 (1988).</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gensburger et al., "<a href='http://scholar.google.com/scholar?q="Brain+basic+fibroblast+growth+factor+stimulates+the+proliferation+of+rat+neuronal+precursor+cells+in+vivo%2C"'>Brain basic fibroblast growth factor stimulates the proliferation of rat neuronal precursor cells in vivo,</a>" FEBS Letts, 217(1):1-5 (1987).</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Gensburger et al., Brain basic fibroblast growth factor stimulates the proliferation of rat neuronal precursor cells in vivo, FEBS Letts, 217(1):1 5 (1987).</td></tr><tr><td class="patent-data-table-td ">33</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hall &amp; Watt, "<a href='http://scholar.google.com/scholar?q="Stem+cells%3A+the+generation+and+maintenance+of+cellular+diversity%2C"'>Stem cells: the generation and maintenance of cellular diversity,</a>" Development, 106:619-633 (1989).</td></tr><tr><td class="patent-data-table-td ">34</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hall &amp; Watt, Stem cells: the generation and maintenance of cellular diversity, Development, 106:619 633 (1989).</td></tr><tr><td class="patent-data-table-td ">35</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hammang et al., "<a href='http://scholar.google.com/scholar?q="Myelination+following+transplantation+of+EGF-responsive+neural+stem+cells+into+a+myelin-deficient+environment"'>Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment</a>", Experimental Neurology 147:84-95 (1997).</td></tr><tr><td class="patent-data-table-td ">36</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hammang et al., Myelination following transplantation of EGF responsive neural stem cells into a myelin deficient environment , Experimental Neurology 147:84 95 (1997).</td></tr><tr><td class="patent-data-table-td ">37</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hoffman et al., "<a href='http://scholar.google.com/scholar?q="Transplantation+of+a+polymer-encapsulated+cell+line+genetically+engineered+to+release+NGF%2C"'>Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF,</a>" Exp. Neurol. 122:100-106 (1993).</td></tr><tr><td class="patent-data-table-td ">38</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hoffman et al., Transplantation of a polymer encapsulated cell line genetically engineered to release NGF, Exp. Neurol. 122:100 106 (1993).</td></tr><tr><td class="patent-data-table-td ">39</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hunter et al., "<a href='http://scholar.google.com/scholar?q="Growth+factor+responses+of+enriched+bipotential+glial+progenitors%2C"'>Growth factor responses of enriched bipotential glial progenitors,</a>" Developmental Brain Research, 54(2):235-248 (1990).</td></tr><tr><td class="patent-data-table-td ">40</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hunter et al., Growth factor responses of enriched bipotential glial progenitors, Developmental Brain Research, 54(2):235 248 (1990).</td></tr><tr><td class="patent-data-table-td ">41</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Isacson et al., "<a href='http://scholar.google.com/scholar?q="A+primate+model+of+Huntingdon%27s+disease%3A+cross-species+implantation+of+striatal+precursor+cells+to+the+excitotoxically+lesioned+baboon+caudate-putamen"'>A primate model of Huntingdon's disease: cross-species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen</a>", Exp. Brain, Res. 75(1): 213-220, (1989).</td></tr><tr><td class="patent-data-table-td ">42</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Isacson et al., A primate model of Huntingdon s disease: cross species implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate putamen , Exp. Brain, Res. 75(1): 213 220, (1989).</td></tr><tr><td class="patent-data-table-td ">43</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Jaenisch et al., "<a href='http://scholar.google.com/scholar?q="The+cells+of+primitive+neuroectodermal+tumours+may+undergo+differentiation+and%2C+eventually%2C+may+be+transformed+to+neurons%2C+glial+cells%2C+and+ependymal+cells"'>The cells of primitive neuroectodermal tumours may undergo differentiation and, eventually, may be transformed to neurons, glial cells, and ependymal cells</a>", Acta Histochemica Supplementband 42: 139-147, (1992).</td></tr><tr><td class="patent-data-table-td ">44</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Jaenisch et al., The cells of primitive neuroectodermal tumours may undergo differentiation and, eventually, may be transformed to neurons, glial cells, and ependymal cells , Acta Histochemica Supplementband 42: 139 147, (1992).</td></tr><tr><td class="patent-data-table-td ">45</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kaplan et al., "<a href='http://scholar.google.com/scholar?q="Neurogenesis+in+the+3-month-old+rat+visual+cortex%2C"'>Neurogenesis in the 3-month-old rat visual cortex,</a>" J. Comp. Neurol., 195:323 (1981).</td></tr><tr><td class="patent-data-table-td ">46</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kaplan et al., Neurogenesis in the 3 month old rat visual cortex, J. Comp. Neurol., 195:323 (1981).</td></tr><tr><td class="patent-data-table-td ">47</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kesslak et al. ( Exp Neurology 94(3): 615 626, 1989).</td></tr><tr><td class="patent-data-table-td ">48</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kesslak et al. (Exp Neurology 94(3): 615-626, 1989).</td></tr><tr><td class="patent-data-table-td ">49</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kumar et al. "<a href='http://scholar.google.com/scholar?q="Identification+of+a+Set+of+Genes+with+Developmental+Down-Regulated+Expression+in+the+Mouse+Brain%2C"'>Identification of a Set of Genes with Developmental Down-Regulated Expression in the Mouse Brain,</a>" Biochemical and Biophysical Research Comm., 185(3):1155-1161 (1992).</td></tr><tr><td class="patent-data-table-td ">50</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kumar et al. Identification of a Set of Genes with Developmental Down Regulated Expression in the Mouse Brain, Biochemical and Biophysical Research Comm., 185(3):1155 1161 (1992).</td></tr><tr><td class="patent-data-table-td ">51</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lendahl et al., "<a href='http://scholar.google.com/scholar?q="CNS+stem+cells+express+a+new+class+of+intermediate+filament+protein%2C"'>CNS stem cells express a new class of intermediate filament protein,</a>" Cell, 60 585-595 (1990).</td></tr><tr><td class="patent-data-table-td ">52</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Lendahl et al., CNS stem cells express a new class of intermediate filament protein, Cell, 60 585 595 (1990).</td></tr><tr><td class="patent-data-table-td ">53</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lin et al., "<a href='http://scholar.google.com/scholar?q="GDNF%3A+A+Glial+Cell+Line-Derived+Neurotrophic+Factor+Midbrain+Dopaminergic+Neuron%2C"'>GDNF: A Glial Cell Line-Derived Neurotrophic Factor Midbrain Dopaminergic Neuron,</a>" Science, 260:1130 (1993).</td></tr><tr><td class="patent-data-table-td ">54</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Lin et al., GDNF: A Glial Cell Line Derived Neurotrophic Factor Midbrain Dopaminergic Neuron, Science, 260:1130 (1993).</td></tr><tr><td class="patent-data-table-td ">55</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lindvall et al. "<a href='http://scholar.google.com/scholar?q="Human+fetal+dopamine+neurons+grafted+into+the+striatum+in+two+patients+with+severe+Parkinson%27s+disease"'>Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease</a>", (Archives of Neurology 46(6): 615-631, 1989).</td></tr><tr><td class="patent-data-table-td ">56</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Lindvall et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson s disease , ( Archives of Neurology 46(6): 615 631, 1989).</td></tr><tr><td class="patent-data-table-td ">57</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lo et al., "<a href='http://scholar.google.com/scholar?q="V-myc+Immortalizationof+Early+Rat+Neural+Crest+Cells+Yields+a+Clonal+Cell+Line+Which+Generates+Both+Glial+and+Adrenergic+Progenitor+Cells%2C"'>V-myc Immortalizationof Early Rat Neural Crest Cells Yields a Clonal Cell Line Which Generates Both Glial and Adrenergic Progenitor Cells,</a>" Developmental Biology, 145:139-153 (1991).</td></tr><tr><td class="patent-data-table-td ">58</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Lo et al., V myc Immortalizationof Early Rat Neural Crest Cells Yields a Clonal Cell Line Which Generates Both Glial and Adrenergic Progenitor Cells, Developmental Biology, 145:139 153 (1991).</td></tr><tr><td class="patent-data-table-td ">59</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Morrison et al., "<a href='http://scholar.google.com/scholar?q="Trophic+stimulation+of+cultured+neurons+from+neonatal+rat+brain+by+epidermal+growth+factor%2C"'>Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor,</a>" Science, 238:72-75 (1987).</td></tr><tr><td class="patent-data-table-td ">60</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Morrison et al., Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor, Science, 238:72 75 (1987).</td></tr><tr><td class="patent-data-table-td ">61</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Potten &amp; Loeffler, "<a href='http://scholar.google.com/scholar?q="Stem+cells%3A+attributes%2C+cycles%2C+spirals%2C+pitfalls+and+uncertainties.+Lessons+for+and+from+the+Crypt%2C"'>Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the Crypt,</a>" Development, 110:1001-1020 (1990).</td></tr><tr><td class="patent-data-table-td ">62</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Potten &amp; Loeffler, Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the Crypt, Development, 110:1001 1020 (1990).</td></tr><tr><td class="patent-data-table-td ">63</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Price et al., "<a href='http://scholar.google.com/scholar?q="Cell+lineage+in+the+rat+cerebral+cortex%3A+a+study+using+retroviral-mediated+gene+transfer"'>Cell lineage in the rat cerebral cortex: a study using retroviral-mediated gene transfer</a>", Development 104(3): 473-482, (1988).</td></tr><tr><td class="patent-data-table-td ">64</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Price et al., Cell lineage in the rat cerebral cortex: a study using retroviral mediated gene transfer , Development 104(3): 473 482, (1988).</td></tr><tr><td class="patent-data-table-td ">65</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Raff et al., "<a href='http://scholar.google.com/scholar?q="A+glial+progenitor+cell+that+develops+in+vitro+into+an+astrocyte+or+an+oligodendrocyte+depending+on+culture+medium%2C"'>A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium,</a>" Nature 303:390-396 (1983).</td></tr><tr><td class="patent-data-table-td ">66</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Raff et al., A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium, Nature 303:390 396 (1983).</td></tr><tr><td class="patent-data-table-td ">67</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Rakic, "<a href='http://scholar.google.com/scholar?q="Limits+of+neurogenesis+in+primates%2C"'>Limits of neurogenesis in primates,</a>" Science 227:1054 (1985).</td></tr><tr><td class="patent-data-table-td ">68</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Rakic, Limits of neurogenesis in primates, Science 227:1054 (1985).</td></tr><tr><td class="patent-data-table-td ">69</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Reh et al., "<a href='http://scholar.google.com/scholar?q="Age+of+differentiation+determines+rat+retinal+germinal+cell+phenotype%3A+Induction+of+differentiation+by+dissociation%2C"'>Age of differentiation determines rat retinal germinal cell phenotype: Induction of differentiation by dissociation,</a>" The Journal of Neuroscience, 9(12):4179-4189 (1989).</td></tr><tr><td class="patent-data-table-td ">70</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Reh et al., Age of differentiation determines rat retinal germinal cell phenotype: Induction of differentiation by dissociation, The Journal of Neuroscience, 9(12):4179 4189 (1989).</td></tr><tr><td class="patent-data-table-td ">71</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Renfranz et al., "<a href='http://scholar.google.com/scholar?q="Region-specific+differentiation+of+the+hippocampal+stem+cell+line+HiB5+upon+implantation+into+the+developing+mammalian+brain"'>Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain</a>" Cell 66:713-729 (1991).</td></tr><tr><td class="patent-data-table-td ">72</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Renfranz et al., Region specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain Cell 66:713 729 (1991).</td></tr><tr><td class="patent-data-table-td ">73</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Reynolds &amp; Weiss., "<a href='http://scholar.google.com/scholar?q="Generation+of+neurons+and+astrocytes+from+isolated+cells+of+the+adult+mammalian+central+nervous+system%2C"'>Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system,</a>" Science, 255:1707-1710 (1992).</td></tr><tr><td class="patent-data-table-td ">74</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Reynolds &amp; Weiss., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, 255:1707 1710 (1992).</td></tr><tr><td class="patent-data-table-td ">75</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Reynolds et al., "<a href='http://scholar.google.com/scholar?q="A+multipotent+EGF-responsive+striatal+embryonic+progenitor+cell+produces+neurons+and+astrocytes%2C"'>A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes,</a>" J. Neurosci. 12(11):4565-4574 (1992).</td></tr><tr><td class="patent-data-table-td ">76</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Reynolds et al., A multipotent EGF responsive striatal embryonic progenitor cell produces neurons and astrocytes, J. Neurosci. 12(11):4565 4574 (1992).</td></tr><tr><td class="patent-data-table-td ">77</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Richardson et al., "<a href='http://scholar.google.com/scholar?q="A+role+for+platelet-derived+growth+factor+in+normal+gliogenesis+in+the+central+nervous+system"'>A role for platelet-derived growth factor in normal gliogenesis in the central nervous system</a>", Cell, 53: 309-319, 1988).</td></tr><tr><td class="patent-data-table-td ">78</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Richardson et al., A role for platelet derived growth factor in normal gliogenesis in the central nervous system , Cell, 53: 309 319, 1988).</td></tr><tr><td class="patent-data-table-td ">79</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Snyder et al., "<a href='http://scholar.google.com/scholar?q="Multipotent+neural+cell+lines+can+engraft+and+participate+in+development+of+mouse+cerebellum"'>Multipotent neural cell lines can engraft and participate in development of mouse cerebellum</a>", Cell 68:33-51 (1992).</td></tr><tr><td class="patent-data-table-td ">80</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Snyder et al., Multipotent neural cell lines can engraft and participate in development of mouse cerebellum , Cell 68:33 51 (1992).</td></tr><tr><td class="patent-data-table-td ">81</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stemple &amp; Anderson, "<a href='http://scholar.google.com/scholar?q="Isolation+of+a+stem+cell+for+neurons+and+glia+from+the+mammalian+neural+crest"'>Isolation of a stem cell for neurons and glia from the mammalian neural crest</a>", Cell 71:1-20, (1992).</td></tr><tr><td class="patent-data-table-td ">82</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Stemple &amp; Anderson, Isolation of a stem cell for neurons and glia from the mammalian neural crest , Cell 71:1 20, (1992).</td></tr><tr><td class="patent-data-table-td ">83</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Temple et al., "<a href='http://scholar.google.com/scholar?q="Divison+and+differentiation+of+isolated+CNS+blast+cells+in+microculture%2C"'>Divison and differentiation of isolated CNS blast cells in microculture,</a>" Nature, 340:471-473 (1989).</td></tr><tr><td class="patent-data-table-td ">84</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Temple et al., Divison and differentiation of isolated CNS blast cells in microculture, Nature, 340:471 473 (1989).</td></tr><tr><td class="patent-data-table-td ">85</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tohyama et al., "<a href='http://scholar.google.com/scholar?q="Nestin+expression+in+embryonic+human+neuroepithelium+and+in+human+neuroepithelial+tumor+cells"'>Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells</a>", Lab. Invest., 66: 303-313, (1992).</td></tr><tr><td class="patent-data-table-td ">86</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Tohyama et al., Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells , Lab. Invest., 66: 303 313, (1992).</td></tr><tr><td class="patent-data-table-td ">87</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Vescovi et al., "<a href='http://scholar.google.com/scholar?q="Continual+proliferation+of+EGF-dependent+progenitor+cells+of+the+embryonic+human+CNS+in+vitro"'>Continual proliferation of EGF-dependent progenitor cells of the embryonic human CNS in vitro</a>"Society for Neuroscience Abstracts, vol. 19, Abstract #360.12 (1993).</td></tr><tr><td class="patent-data-table-td ">88</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Vescovi et al., Continual proliferation of EGF dependent progenitor cells of the embryonic human CNS in vitro Society for Neuroscience Abstracts , vol. 19, Abstract 360.12 (1993).</td></tr><tr><td class="patent-data-table-td ">89</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wendt et al. "<a href='http://scholar.google.com/scholar?q="Regeneration+of+rat+hippocampal+fimbria+fibers+after+fimbria+transection+and+peripheral+nerve+or+fetal+hippocampal+implantation."'>Regeneration of rat hippocampal fimbria fibers after fimbria transection and peripheral nerve or fetal hippocampal implantation.</a>", (Exp. Neurology 79(2): 452-461, 1983).</td></tr><tr><td class="patent-data-table-td ">90</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Wendt et al. Regeneration of rat hippocampal fimbria fibers after fimbria transection and peripheral nerve or fetal hippocampal implantation. , ( Exp. Neurology 79(2): 452 461, 1983).</td></tr><tr><td class="patent-data-table-td ">91</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Yamada et al., Growth of cells in hormonally defined media Book A Cold Spring Harbor Laboratory, 1982 Cold Spring Harbor conferences on cell proliferation, vol. 9, 131 143.</td></tr><tr><td class="patent-data-table-td ">92</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Yamada et al., Growth of cells in hormonally defined media--Book A Cold Spring Harbor Laboratory, 1982--Cold Spring Harbor conferences on cell proliferation, vol. 9, 131-143.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6498018">US6498018</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 4, 1998</td><td class="patent-data-table-td patent-date-value">Dec 24, 2002</td><td class="patent-data-table-td ">Cytotherapeutics, Inc.</td><td class="patent-data-table-td ">Cultures of human CNS neural stem cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6777233">US6777233</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 2002</td><td class="patent-data-table-td patent-date-value">Aug 17, 2004</td><td class="patent-data-table-td ">Stemcells California, Inc.</td><td class="patent-data-table-td ">Cell culture of nervous system cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6897061">US6897061</a></td><td class="patent-data-table-td patent-date-value">Aug 23, 2000</td><td class="patent-data-table-td patent-date-value">May 24, 2005</td><td class="patent-data-table-td ">Spinal Cord Society</td><td class="patent-data-table-td ">Into multipotent cells (neurons/astrocytes/oligodendrocytes) in vitro; stem cells; nerve/fibroblast growth factors; extracellular matrices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7132286">US7132286</a></td><td class="patent-data-table-td patent-date-value">Jun 18, 2002</td><td class="patent-data-table-td patent-date-value">Nov 7, 2006</td><td class="patent-data-table-td ">Psychiatric Genomics, Inc.</td><td class="patent-data-table-td ">Generation of preferential mammalian cells; obtain neurons, incubate with valproate, monitor neuronal cell phenotypes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7132287">US7132287</a></td><td class="patent-data-table-td patent-date-value">Jun 18, 2002</td><td class="patent-data-table-td patent-date-value">Nov 7, 2006</td><td class="patent-data-table-td ">Psychiatric Genomics, Inc.</td><td class="patent-data-table-td ">Method for neural stem cell differentiation using 5HT-1A agonists</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7442545">US7442545</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2004</td><td class="patent-data-table-td patent-date-value">Oct 28, 2008</td><td class="patent-data-table-td ">Stemcell Technologies, Inc.</td><td class="patent-data-table-td ">Distinguising neural stem cells from neural progenitor cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7514259">US7514259</a></td><td class="patent-data-table-td patent-date-value">Feb 12, 2001</td><td class="patent-data-table-td patent-date-value">Apr 7, 2009</td><td class="patent-data-table-td ">Schepens Eye Research Institute</td><td class="patent-data-table-td ">Derived from the neuroretina of the eye ex vivo and in vivo</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7622108">US7622108</a></td><td class="patent-data-table-td patent-date-value">Aug 22, 2005</td><td class="patent-data-table-td patent-date-value">Nov 24, 2009</td><td class="patent-data-table-td ">Bioe, Inc.</td><td class="patent-data-table-td ">Multi-lineage progenitor cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7670596">US7670596</a></td><td class="patent-data-table-td patent-date-value">Apr 20, 2005</td><td class="patent-data-table-td patent-date-value">Mar 2, 2010</td><td class="patent-data-table-td ">Bioe, Inc.</td><td class="patent-data-table-td ">Multi-lineage progenitor cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7727763">US7727763</a></td><td class="patent-data-table-td patent-date-value">Apr 17, 2007</td><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td ">Bioe, Llc</td><td class="patent-data-table-td ">Differentiation of multi-lineage progenitor cells to respiratory epithelial cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7838292">US7838292</a></td><td class="patent-data-table-td patent-date-value">Mar 29, 2002</td><td class="patent-data-table-td patent-date-value">Nov 23, 2010</td><td class="patent-data-table-td ">University Of Louisville Research Foundation, Inc.</td><td class="patent-data-table-td ">isolated human olfactory stem cell prepared by culturing human tissue from olfactory neuroepithelium to form neurospheres; treating a neurological disorder such as spinal cord injury, Parkinson&#39;s disease, amyotrophic lateral sclerosis and multiple sclerosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8163275">US8163275</a></td><td class="patent-data-table-td patent-date-value">Oct 5, 2009</td><td class="patent-data-table-td patent-date-value">Apr 24, 2012</td><td class="patent-data-table-td ">Bioe Llc</td><td class="patent-data-table-td ">Multi-lineage progenitor cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1674566A1?cl=en">EP1674566A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 8, 2004</td><td class="patent-data-table-td patent-date-value">Jun 28, 2006</td><td class="patent-data-table-td ">Keio University</td><td class="patent-data-table-td ">Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2393918A1?cl=en">EP2393918A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 3, 2010</td><td class="patent-data-table-td patent-date-value">Dec 14, 2011</td><td class="patent-data-table-td ">Keio University</td><td class="patent-data-table-td ">Culture method of embryoid bodies and/or neural stem cells derived from human differentiated cell-derived pluripotent stem cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001042421A2?cl=en">WO2001042421A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 7, 2000</td><td class="patent-data-table-td patent-date-value">Jun 14, 2001</td><td class="patent-data-table-td ">Eric Shannon Hayes</td><td class="patent-data-table-td ">Long-term cell culture compositions and genetically modified animals derived therefrom</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013157850A1?cl=en">WO2013157850A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 17, 2013</td><td class="patent-data-table-td patent-date-value">Oct 24, 2013</td><td class="patent-data-table-td ">Jeong Chan Ra</td><td class="patent-data-table-td ">Method for manufacturing stem cell having appropriate size for intravascular administration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014003319A1?cl=en">WO2014003319A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 23, 2013</td><td class="patent-data-table-td patent-date-value">Jan 3, 2014</td><td class="patent-data-table-td ">Jeong-Chan Ra</td><td class="patent-data-table-td ">High-concentration stem cell production method</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S405000">435/405</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S325000">435/325</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S368000">435/368</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S404000">435/404</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S377000">435/377</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S387000">435/387</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S406000">435/406</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S389000">435/389</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S384000">435/384</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0048000000">A61K48/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0033500000">G01N33/50</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0035120000">A61K35/12</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0015090000">C12N15/09</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0033150000">G01N33/15</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0005079700">C12N5/0797</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2501/392">C12N2501/392</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K35/12">A61K35/12</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2501/11">C12N2501/11</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2500/99">C12N2500/99</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2501/115">C12N2501/115</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K48/00">A61K48/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2500/34">C12N2500/34</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K35/30">A61K35/30</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2501/105">C12N2501/105</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2501/235">C12N2501/235</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=G01N33/5005">G01N33/5005</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2500/25">C12N2500/25</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2503/02">C12N2503/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N5/0623">C12N5/0623</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=_8pQBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K2035/126">A61K2035/126</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K35/30</span>, <span class="nested-value">G01N33/50D</span>, <span class="nested-value">C12N5/06B8P</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Feb 15, 2012</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 19, 2010</td><td class="patent-data-table-td ">SULP</td><td class="patent-data-table-td ">Surcharge for late payment</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 4, 2008</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIM 1 IS DETERMINED TO BE PATENTABLE AS AMENDED. CLAIM 2, DEPENDENT ON AN AMENDED CLAIM, IS DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 25, 2008</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 15, 2008</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 20, 2007</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20071002</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 26, 2006</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">STEMCELLS CALIFORNIA, INC., CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STEMCELLS, INC.;REEL/FRAME:017811/0546</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20021219</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 19, 2006</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">STEMCELLS, INC., CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:CYTOTHERAPEUTICS, INC.;REEL/FRAME:017823/0513</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20000523</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 12, 2006</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">CYTOTHERAPEUTICS, INC., RHODE ISLAND</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARPENTER, MELISSA K.;REEL/FRAME:017783/0029</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19980126</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 16, 2004</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 6, 2003</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">STEMCELLS CALIFORNIA, INC., CALIFORNIA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STEMCELLS, INC.;REEL/FRAME:014137/0072</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20021219</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">STEMCELLS CALIFORNIA, INC. 3155 PORTER DRIVEPALO A</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STEMCELLS, INC. /AR;REEL/FRAME:014137/0072</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 5, 2001</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U1rl4aas3aPx_ObydK5fKzpM8XBEA\u0026id=_8pQBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U0tieg7bzRMe5bg9rVD2YopTWEbYA\u0026id=_8pQBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U3c-o4jaCnRGDMNqANH0I9T9diolA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Medium_for_proliferating_central_nervous.pdf?id=_8pQBAABERAJ\u0026output=pdf\u0026sig=ACfU3U19zc1pZNaoe1ogNRZzxtn3IMWPGA"},"sample_url":"http://www.google.com/patents/reader?id=_8pQBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>